Appearance of Plasma Amino Acids Following Consumption of an Oral Nutrition Supplement
Not Applicable
Completed
- Conditions
- Healthy Subjects
- Registration Number
- NCT02717234
- Lead Sponsor
- Société des Produits Nestlé (SPN)
- Brief Summary
To assess the effect of consumption of an oral nutrition supplement on Arginine, a blood marker of nutritional intake
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- Healthy subject (absence of metabolic disorder, heart disease, endocrine disease, cancer)
- Discontinued use of omega 3 fatty acid supplements - 10 days prior to testing
- Willing to provide signed informed consent
Exclusion Criteria
- Smoker
- Patients with potential for non-compliance
- Patients with allergy to ingredients in test products (i.e. milk protein, fish oil)
- Subject who in the Investigator's assessment cannot be expected to comply with study protocol
- Currently participating in another conflicting clinical trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Change in plasma arginine levels in µmol/L Pre-consumption, 30, 60, 120, 180, 240 minutes
- Secondary Outcome Measures
Name Time Method Change in plasma phospholipid Eicosapentaenoic acid (EPA) in µg/ml Pre-consumption, 30, 60, 120, 180, 240 minutes Change in plasma-free phospholipid Eicosapentaenoic acid (EPA) in µg/ml Pre-consumption, 30, 60, 120, 180, 240 minutes